We demonstrate here that PMIBcr/Abl‐R6 has multiple functions in Ph+ leukemias: interrupting the oligomerization of Bcr/Abl, inducing Bcr/Abl degradation, and activating p53 in p53 wild‐type cancer cells. This evidence concerns the gene BCR and cancer.